Murphy Pohlad Asset Management LLC Amgen Inc Transaction History

Murphy Pohlad Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $213,788 - $236,505	-975 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $810,871 - $950,034	-3,820 Reduced 79.67%	975 $207,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $58,395 - $64,785	-250 Reduced 4.96%	4,795 $1.17 Million
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $738,960 - $861,138	3,330 Added 194.17%	5,045 $1.26 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $102,542 - $114,035	437 Added 34.19%	1,715 $435,000

Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $18,087 - $20,388	-100 Reduced 7.26%	1,278 $242,000
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $230,525 - $263,198	1,378	1,378 $256,000

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.